172 related articles for article (PubMed ID: 19289120)
1. Anti-melanin antibodies are increased in sera in Parkinson's disease.
Double KL; Rowe DB; Carew-Jones FM; Hayes M; Chan DK; Blackie J; Corbett A; Joffe R; Fung VS; Morris J; Riederer P; Gerlach M; Halliday GM
Exp Neurol; 2009 Jun; 217(2):297-301. PubMed ID: 19289120
[TBL] [Abstract][Full Text] [Related]
2. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
Mogi M; Kondo T; Mizuno Y; Nagatsu T
Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
[TBL] [Abstract][Full Text] [Related]
3. Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease.
Fiszer U; Fredrikson S; Członkowska A
J Neurol Sci; 1996 Jul; 139(1):66-70. PubMed ID: 8836974
[TBL] [Abstract][Full Text] [Related]
4. Individual dopaminergic neurons show raised iron levels in Parkinson disease.
Oakley AE; Collingwood JF; Dobson J; Love G; Perrott HR; Edwardson JA; Elstner M; Morris CM
Neurology; 2007 May; 68(21):1820-5. PubMed ID: 17515544
[TBL] [Abstract][Full Text] [Related]
5. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
Ferrer I; Perez E; Dalfó E; Barrachina M
Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.
Knott C; Stern G; Wilkin GP
Mol Cell Neurosci; 2000 Dec; 16(6):724-39. PubMed ID: 11124893
[TBL] [Abstract][Full Text] [Related]
7. Circulating interleukin-10 and interleukin-12 in Parkinson's disease.
Rentzos M; Nikolaou C; Andreadou E; Paraskevas GP; Rombos A; Zoga M; Tsoutsou A; Boufidou F; Kapaki E; Vassilopoulos D
Acta Neurol Scand; 2009 May; 119(5):332-7. PubMed ID: 18976327
[TBL] [Abstract][Full Text] [Related]
8. Excessive dopamine neuron loss in progressive supranuclear palsy.
Murphy KE; Karaconji T; Hardman CD; Halliday GM
Mov Disord; 2008 Mar; 23(4):607-10. PubMed ID: 18163454
[TBL] [Abstract][Full Text] [Related]
9. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra.
Greffard S; Verny M; Bonnet AM; Beinis JY; Gallinari C; Meaume S; Piette F; Hauw JJ; Duyckaerts C
Arch Neurol; 2006 Apr; 63(4):584-8. PubMed ID: 16606773
[TBL] [Abstract][Full Text] [Related]
10. The progression of Parkinson disease: a hypothesis.
Lang AE
Neurology; 2007 Mar; 68(12):948-52. PubMed ID: 17372132
[TBL] [Abstract][Full Text] [Related]
11. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
12. [Methods for the early diagnosis of Parkinson's disease].
Becker G
Nervenarzt; 2003 Mar; 74 Suppl 1():S7-11. PubMed ID: 12624678
[TBL] [Abstract][Full Text] [Related]
13. Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.
Gerlach M; Riederer P; Double KL
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S185-8. PubMed ID: 18585086
[TBL] [Abstract][Full Text] [Related]
14. The antibodies against Bordetella pertussis in sera of patients with Parkinson's disease and other non-neurological diseases.
Fiszer U; Tomik B; Grzesiowski P; Krygowska-Wajs A; Walory J; Michałowska M; Palasik W
Acta Neurol Scand; 2004 Aug; 110(2):113-7. PubMed ID: 15242419
[TBL] [Abstract][Full Text] [Related]
15. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
16. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control.
Koziorowski D; Friedman A; Arosio P; Santambrogio P; Dziewulska D
Parkinsonism Relat Disord; 2007 May; 13(4):214-8. PubMed ID: 17275395
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease.
Arai T; Fukae J; Hatano T; Kubo S; Ohtsubo T; Nakabeppu Y; Mori H; Mizuno Y; Hattori N
Acta Neuropathol; 2006 Aug; 112(2):139-45. PubMed ID: 16773329
[TBL] [Abstract][Full Text] [Related]
18. Biomolecular investigation of human substantia nigra in Parkinson's disease by synchrotron radiation Fourier transform infrared microspectroscopy.
Szczerbowska-Boruchowska M; Dumas P; Kastyak MZ; Chwiej J; Lankosz M; Adamek D; Krygowska-Wajs A
Arch Biochem Biophys; 2007 Mar; 459(2):241-8. PubMed ID: 17274943
[TBL] [Abstract][Full Text] [Related]
19. Humoral response against glial derived antigens in Parkinson's disease.
Papuć E; Kurzepa J; Kurys-Denis E; Grabarska A; Krupski W; Rejdak K
Neurosci Lett; 2014 Apr; 566():77-81. PubMed ID: 24594199
[TBL] [Abstract][Full Text] [Related]
20. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
Fedorow H; Tribl F; Halliday G; Gerlach M; Riederer P; Double KL
Prog Neurobiol; 2005 Feb; 75(2):109-24. PubMed ID: 15784302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
